PT1315730E - Derivados de 1-[alquil],1-[(heteroaril)-alquil] e 1-[(aril)-alquil]-7-piridinil-imidazo[1,2-a]pirimidin-5(1h)-ona - Google Patents

Derivados de 1-[alquil],1-[(heteroaril)-alquil] e 1-[(aril)-alquil]-7-piridinil-imidazo[1,2-a]pirimidin-5(1h)-ona

Info

Publication number
PT1315730E
PT1315730E PT01980396T PT01980396T PT1315730E PT 1315730 E PT1315730 E PT 1315730E PT 01980396 T PT01980396 T PT 01980396T PT 01980396 T PT01980396 T PT 01980396T PT 1315730 E PT1315730 E PT 1315730E
Authority
PT
Portugal
Prior art keywords
group
alkyl group
ring
optionally substituted
alquil
Prior art date
Application number
PT01980396T
Other languages
English (en)
Inventor
Severine Marguerie
Mourad Saady
Philippe Yaiche
Alistair Lochead
Original Assignee
Mitsubishi Pharma Corp
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp, Sanofi Aventis filed Critical Mitsubishi Pharma Corp
Publication of PT1315730E publication Critical patent/PT1315730E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
PT01980396T 2000-09-01 2001-08-31 Derivados de 1-[alquil],1-[(heteroaril)-alquil] e 1-[(aril)-alquil]-7-piridinil-imidazo[1,2-a]pirimidin-5(1h)-ona PT1315730E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00402411A EP1184384A1 (en) 2000-09-01 2000-09-01 1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives
PCT/EP2001/010725 WO2002018385A1 (en) 2000-09-01 2001-08-31 1-[ALKYL], 1-[(HETEROARYL)ALKYL] AND 1-[(ARYL)ALKYL]-7-PYRIDINYL-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES

Publications (1)

Publication Number Publication Date
PT1315730E true PT1315730E (pt) 2004-10-29

Family

ID=8173838

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01980396T PT1315730E (pt) 2000-09-01 2001-08-31 Derivados de 1-[alquil],1-[(heteroaril)-alquil] e 1-[(aril)-alquil]-7-piridinil-imidazo[1,2-a]pirimidin-5(1h)-ona

Country Status (17)

Country Link
US (2) US7067521B2 (pt)
EP (2) EP1184384A1 (pt)
JP (1) JP4958379B2 (pt)
KR (1) KR100775192B1 (pt)
CN (1) CN1247584C (pt)
AR (1) AR030588A1 (pt)
AT (1) ATE270293T1 (pt)
AU (2) AU2002212248B2 (pt)
CA (1) CA2419875C (pt)
DE (1) DE60104130T2 (pt)
DK (1) DK1315730T3 (pt)
EA (1) EA004933B1 (pt)
ES (1) ES2223008T3 (pt)
PT (1) PT1315730E (pt)
SI (1) SI1315730T1 (pt)
TR (1) TR200402519T4 (pt)
WO (1) WO2002018385A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1184384A1 (en) * 2000-09-01 2002-03-06 Sanofi-Synthelabo 1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives
EP1340759A1 (en) 2002-02-28 2003-09-03 Sanofi-Synthelabo 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
AU2005206557A1 (en) 2004-01-22 2005-08-04 Amgen Inc. Substituted heterocyclic compounds and methods of use
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
FR2928070A1 (fr) * 2008-02-27 2009-09-04 Sumitomo Chemical Co Composition agricole, utilisation d'un compose pour sa production et procede pour matriser ou prevenir les maladies des plantes.
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SG10201403138WA (en) * 2009-07-02 2014-08-28 Sanofi Sa Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof and pharmaceutical use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
US6098753A (en) * 1998-06-05 2000-08-08 Pratt & Whitney Canada Corp. System for delivering pressurized lubricant fluids to an interior of a rotating hollow shaft
TWI241298B (en) * 1998-09-25 2005-10-11 Mitsubishi Chem Corp Pyrimidone derivatives
EP1184384A1 (en) * 2000-09-01 2002-03-06 Sanofi-Synthelabo 1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives

Also Published As

Publication number Publication date
DE60104130D1 (de) 2004-08-05
DK1315730T3 (da) 2004-10-25
EP1184384A1 (en) 2002-03-06
JP2004507545A (ja) 2004-03-11
CA2419875A1 (en) 2002-03-07
SI1315730T1 (en) 2005-02-28
CA2419875C (en) 2010-06-15
EA200300150A1 (ru) 2003-08-28
KR100775192B1 (ko) 2007-11-12
CN1451006A (zh) 2003-10-22
ATE270293T1 (de) 2004-07-15
DE60104130T2 (de) 2005-03-10
EP1315730A1 (en) 2003-06-04
AU2002212248B2 (en) 2007-01-04
TR200402519T4 (tr) 2004-12-21
KR20030029892A (ko) 2003-04-16
AU1224802A (en) 2002-03-13
EP1315730B1 (en) 2004-06-30
WO2002018385A1 (en) 2002-03-07
ES2223008T3 (es) 2005-02-16
EA004933B1 (ru) 2004-10-28
US7067521B2 (en) 2006-06-27
US7608624B2 (en) 2009-10-27
CN1247584C (zh) 2006-03-29
JP4958379B2 (ja) 2012-06-20
US20040044010A1 (en) 2004-03-04
US20060148825A1 (en) 2006-07-06
AR030588A1 (es) 2003-08-27

Similar Documents

Publication Publication Date Title
DE60140860D1 (de) 2-aminonicotinamid-derivate und ihre verwendung als vegf-rezeptor tyrosin-kinase inhibitoren
EA200400236A1 (ru) Производные замещенного 2-пиримидинил-6,7,8,9-тетрагидропиримидо[1,2-a]пиримидин-4-она и 7-пиримидинил-2,3-дигидроимидазо[1,2-a]пиримидин-5(1h)она для нейродегенеративных нарушений
TW200505922A (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
EA200400936A1 (ru) ГЕТЕРОАРИЛЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 2-ПИРИДИНИЛ- И 2-ПИРИМИДИНИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА
PT1315730E (pt) Derivados de 1-[alquil],1-[(heteroaril)-alquil] e 1-[(aril)-alquil]-7-piridinil-imidazo[1,2-a]pirimidin-5(1h)-ona
AR043658A1 (es) Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona
EA200400237A1 (ru) ПРОИЗВОДНЫЕ ЗАМЕЩЕННОГО 2-ПИРИДИНИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА И 7-ПИРИДИНИЛ-2,3-ДИГИДРОИМИДАЗО[1,2-a]ПИРИМИДИН-5(1H)ОНА
TW200510418A (en) Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido [1, 2-a] pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido [1, 2-a] pyrimidin-6-one derivatives
AR030587A1 (es) Derivados de 2-piridinil-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona y 7-piridinil-2,3-dihidroimidazo[1,2-a]pirimidin-5(1h)-ona
DE69635857D1 (de) Pyrrolderivate und medizinische zubereitung.
EP0882714A4 (en) SUBSTITUTED VINYLPYRIDINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
AR038620A1 (es) Derivados de 1-(alquil), 1-((heteroaril)alquil) y 1-((aril) alquil)-7-(pirimidin-4-il)-imidazo(1,2-a)pirimidin-5(1h)-ona
HK1061674A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
DK1209166T3 (da) Hidtil ukendte A-500 359-derivater
PT1315731E (pt) Derivados de 2-piridinil-6,7,8,9-tetra-hidropirimido [1,2-a] pirimidin-4-ona e 7-piridinil-2,3-di-hidroimidazol [1,2-a]pirimidin-5 (1h) ona
TH65145A (th) อนุพันธ์ของซับสทิทิวเทด 2-พิริมิดินิล-6, 7, 8, 9-เททระไฮโดรพิริมิโด[1, 2-a]พิริมิดิน-4-โอน และ 7-พิริมิดินิล-2, 3-ไดไฮโดรอิมิดาโซ[1, 2-a]พิริมิดิน-5(1H)-โอน
DE69722630D1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
TH68721A (th) อนุพันธ์1-[อัลคิล], 1-[(เฮทเทอโรเอริล)อัลคิล] และอนุพันธ์ 1-[(เอริล)อัลคิล)]-7-พิริดิน-4-อิล อิมิดาโซ[1,2-a]พิริมิดิน-5(1H)-โอน
TH54170A (th) อนุพันธ์ 2-พิริดิน-6,7,8,9-เททราไฮโดรพิริมิโด[1,2-a]พิริมิดิน-4-โอน และ 7-พิริดินิล-2,3-ไดไฮโดรอิมิดาโซล[1,2-a]พิริมิดิน-5(1H)โอน
TH65083A (th) อนุพันธ์ของซับสทิทิวเทด 2-พิริตินิล-6,7,8,9-เททระไฮโดรพิริมิโด[1,2-a]พิริมิติน-4-โอน และ 7-พิริตินิล-2,3-ไดไฮโดรอิมิดาโซ[1,2-a]พิริมิติน-5(1H) โอน